tiprankstipranks
Trending News
More News >
Aarti Pharmalabs Limited (IN:AARTIPHARM)
:AARTIPHARM
India Market
Advertisement

Aarti Pharmalabs Limited (AARTIPHARM) Ratios

Compare
0 Followers

Aarti Pharmalabs Limited Ratios

IN:AARTIPHARM's free cash flow for Q4 2025 was ₹0.51. For the 2025 fiscal year, IN:AARTIPHARM's free cash flow was decreased by ₹ and operating cash flow was ₹0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.01 1.94 1.94 1.95 18.55
Quick Ratio
1.12 1.01 1.01 0.94 -55.75K
Cash Ratio
0.01 0.03 0.03 0.04 17.22
Solvency Ratio
0.39 0.35 0.35 0.38 4.93K
Operating Cash Flow Ratio
0.00 0.31 0.31 0.44 -12.10
Short-Term Operating Cash Flow Coverage
0.00 0.82 0.82 1.23 >-0.01
Net Current Asset Value
₹ 4.06B₹ 5.21B₹ 5.21B₹ 4.83B₹ 1.50M
Leverage Ratios
Debt-to-Assets Ratio
0.14 0.11 0.11 0.10 2.16K
Debt-to-Equity Ratio
0.21 0.16 0.16 0.14 2.28K
Debt-to-Capital Ratio
0.17 0.14 0.14 0.12 1.00
Long-Term Debt-to-Capital Ratio
0.05 <0.01 <0.01 <0.01 0.79
Financial Leverage Ratio
1.46 1.47 1.47 1.43 1.06
Debt Service Coverage Ratio
1.20 1.09 1.09 1.18 0.52
Interest Coverage Ratio
12.95 18.17 18.17 13.39 -475.75
Debt to Market Cap
0.05 0.06 0.06 0.09 0.13
Interest Debt Per Share
48.75 33.37 33.37 25.99 37.63
Net Debt to EBITDA
0.86 0.67 0.67 0.55 1.63
Profitability Margins
Gross Profit Margin
50.71%21.53%21.53%39.87%16.11%
EBIT Margin
19.60%17.50%17.50%14.49%13.05%
EBITDA Margin
24.23%21.53%21.53%17.70%17.55%
Operating Profit Margin
19.20%17.23%17.23%14.49%>-0.01%
Pretax Profit Margin
18.11%16.55%16.55%13.41%>-0.01%
Net Profit Margin
13.69%11.95%11.95%9.95%>-0.01%
Continuous Operations Profit Margin
13.69%11.95%11.95%9.95%10.24%
Net Income Per EBT
75.60%72.18%72.18%74.20%100.00%
EBT Per EBIT
94.34%96.06%96.06%92.53%100.21%
Return on Assets (ROA)
9.17%8.40%8.40%8.67%-48.79%
Return on Equity (ROE)
14.29%12.34%12.34%12.42%-51.57%
Return on Capital Employed (ROCE)
16.61%16.57%16.57%17.19%-51.46%
Return on Invested Capital (ROIC)
11.09%10.47%10.47%11.28%-2.53%
Return on Tangible Assets
9.50%8.66%8.66%8.84%0.32%
Earnings Yield
3.38%5.33%5.33%7.74%>-0.01%
Efficiency Ratios
Receivables Turnover
3.38 3.50 3.50 4.26 3.07
Payables Turnover
3.45 3.77 3.77 3.45 4.67
Inventory Turnover
1.63 2.22 2.22 1.94 2.11
Fixed Asset Turnover
1.38 1.64 1.64 1.97 1.26
Asset Turnover
0.67 0.70 0.70 0.87 7.55K
Working Capital Turnover Ratio
5.85 2.99 2.99 6.89 6.04K
Cash Conversion Cycle
225.82 172.19 172.19 167.63 214.17
Days of Sales Outstanding
107.94 104.41 104.41 85.71 119.07
Days of Inventory Outstanding
223.63 164.70 164.70 187.85 173.33
Days of Payables Outstanding
105.74 96.92 96.92 105.93 78.23
Operating Cycle
331.56 269.11 269.11 273.57 292.40
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 23.87 23.87 29.02 -0.01
Free Cash Flow Per Share
0.00 1.94 1.94 15.82 -15.59
CapEx Per Share
0.00 21.93 21.93 13.20 15.58
Free Cash Flow to Operating Cash Flow
0.00 0.08 0.08 0.55 1.37K
Dividend Paid and CapEx Coverage Ratio
0.00 1.00 1.00 1.91 >-0.01
Capital Expenditure Coverage Ratio
0.00 1.09 1.09 2.20 >-0.01
Operating Cash Flow Coverage Ratio
0.00 0.76 0.76 1.23 >-0.01
Operating Cash Flow to Sales Ratio
0.00 0.12 0.12 0.14 >-0.01
Free Cash Flow Yield
0.00%0.43%0.43%5.73%-5.41%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
29.61 18.75 18.75 12.92 -33.87K
Price-to-Sales (P/S) Ratio
4.05 2.24 2.24 1.29 2.19
Price-to-Book (P/B) Ratio
3.96 2.31 2.31 1.60 17.46K
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 231.51 231.51 17.44 -18.49
Price-to-Operating Cash Flow Ratio
0.00 18.80 18.80 9.51 -25.32K
Price-to-Earnings Growth (PEG) Ratio
-13.49 1.55 1.55 >-0.01 355.44
Price-to-Fair Value
3.96 2.31 2.31 1.60 17.46K
Enterprise Value Multiple
17.59 11.07 11.07 7.81 14.10
Enterprise Value
82.91B 43.29B 43.29B 26.89B 29.53B
EV to EBITDA
17.59 11.07 11.07 7.81 14.10
EV to Sales
4.26 2.38 2.38 1.38 2.47
EV to Free Cash Flow
0.00 246.40 246.40 18.76 -20.91
EV to Operating Cash Flow
0.00 20.01 20.01 10.23 -28.63K
Tangible Book Value Per Share
208.43 185.35 185.35 167.37 -2.65
Shareholders’ Equity Per Share
219.49 193.85 193.85 171.97 0.02
Tax and Other Ratios
Effective Tax Rate
0.24 0.28 0.28 0.26 -429.48
Revenue Per Share
214.62 200.30 200.30 214.64 131.70
Net Income Per Share
29.39 23.93 23.93 21.35 >-0.01
Tax Burden
0.76 0.72 0.72 0.74 1.00
Interest Burden
0.92 0.95 0.95 0.93 >-0.01
Research & Development to Revenue
0.00 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.00 <0.01 <0.01 <0.01 <0.01
Stock-Based Compensation to Revenue
0.00 <0.01 <0.01 0.00 0.00
Income Quality
0.00 1.00 1.00 1.01 1.34
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis